ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 668281 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 668281; 2) Community: the network communities that were significantly associated with the response to NSC 668281; 3) Molecule: the relationships between components within communities and NSC 668281; 4) MDR: the compounds that were significantly associated with the NSC 668281.

NSC Compound Enrichment Correlation
NSC 728128 1-[3-(1-benzyl-4-chloro-2,5-dioxo-2,5-dihydro-1H-3-pyrrolyla mino)phenylcarboxamido]-2,3-dichlorobenzene 0.00770426557728506 0.28760234
NSC 734307 3,4-Dihydroxy-N(3-O-methyl-estra-1,3,5(10)-trien-ol-17b-yl)c innamide 0.00770426557728506 0.25127664
NSC 736201 Indenoisoquinoline derivative 0.00770426557728506 0.61812902
NSC 73735 B 3845 0.00770426557728506 0.47186765
NSC 750324 Null 0.00770426557728506 0.15129801
NSC 757113 METHOTREXATE(+/-) 0.00770426557728506 0.50819068
NSC 105014 Cladribine 0.00803384002766641 0.58493231
NSC 119915 3-(4,5,6-trihydroxy-3-oxo-3H-xanthen-9-yl)propanoic acid 0.00803384002766641 0.016270272
NSC 148790 Card-20(22)-enolide, 16-(acetyloxy)-3,14-dihydroxy-, (3.beta.,5.beta.,16.beta.)- (9CI) 0.00803384002766641 0.45976547
NSC 163424 4-Quinazolinamine, 2-[2-(1-pyrrolidinylazo)phenyl]- 0.00803384002766641 0.19466401
Total:100  Current:28    [First] [Prev] [Next] [Last]